Barclays lowered the firm’s price target on Keurig Dr Pepper (KDP) to $37 from $38 and keeps an Overweight rating on the shares. The firm updated the company’s model after hosting management for meetings.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper reaffirms view of high-single-digit FY25 adjusted EPS growth
- Keurig Dr Pepper Reaffirms 2025 Financial Guidance
- Keurig Dr Pepper: Strong Growth Potential and Undervalued Stock with Strategic Expansion
- Keurig Dr Pepper Approves Key Proposals at Annual Meeting
- Morgan Stanley sees ‘opportune entry point’ into Keurig Dr Pepper